Regression of Idiopathic Thrombocytopenic Purpura in a Patient With Eradication of Hepatitis C Virus by Direct-Acting Antivirals

Hepatology. 2020 Jan;71(1):389-391. doi: 10.1002/hep.30900. Epub 2019 Oct 11.

Authors

Affiliations

¹ Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Naka-ku, Hiroshima, Japan.
² Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.

PMID: 31432523
DOI: 10.1002/hep.30900

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Antiviral Agents / therapeutic use*
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / drug therapy*
Humans
Male
Purpura, Thrombocytopenic, Idiopathic / complications
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Remission Induction

Substances

Antiviral Agents